glp-1 agonists and fertility Frontiers The hidden impact of GLP‐1

Hunger still occurs, but it lacks the urgent, demanding quality that characterized eating before treatment

The authors highlighted their stepwise approach to insulin reduction, which involved prompt weekly insulin dose decreases of 1020% when preprandial or fasting glucose levels were consistently between 80 and 130 mg/dL

5 GLP-1 trends to expect in 2026: Expanded uses, oral options, and more Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market

Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research

In conclusion, while the association between metformin and the incidence of certain cancers remains a subject of debate, metformin exhibits significant protective effects against multiple types of tumors, demonstrating efficacy in inhibiting tumor cell proliferation and progression, reducing cancer risk, and improving cancer-related outcomes [107]